Aspirin removal in patients with a CH-VAD heart pump
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether it is safe to stop taking aspirin after getting a CH-VAD heart pump, which helps pump blood for people with advanced heart failure. If you are taking aspirin to prevent blood clots, this trial will help doctors learn if you can stop it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a CH-VAD heart pump, and it is your first heart pump.
- You do not need other heart support devices before or after the pump.
- You are not required by your doctor to take blood thinners like aspirin after the pump.
- You have no known allergy to aspirin.
- You can take pills by mouth after the pump and for the first week.
- You are willing to join and follow the study plan, including follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if taking aspirin along with a standard blood thinner helps people with a HeartMate3 heart pump have fewer bleeding or clotting problems. It is for people who have had their pump for at least 3 months.
This trial tests whether older adults with stable heart disease can safely stop taking daily aspirin after two years without increasing the risk of heart attack or stroke. It may help reduce the side effects of long-term aspirin use.
This study compares two blood thinners for people who have a HeartMate 3 left ventricular assist device (LVAD). The goal is to see if the newer medicine, apixaban, works better or has fewer side effects than the standard medicine, warfarin.
This trial studies a “double anti-platelet” medicine plan (aspirin plus clopidogrel) after closing the left atrial appendage, a procedure used to reduce stroke risk in some heart rhythm conditions. It aims to find a safer, better medicine strategy for people who cannot take standard blood thinners.
This trial is for people who have had a TAVI procedure to replace a narrowed heart valve, and it tests whether it is safe to skip blood thinners afterward. The goal is to find the best way to protect your health without unnecessary medication.
This study compares two approaches after a left atrial appendage closure (LAAC) procedure: taking no blood thinner versus taking just one antiplatelet medication. It aims to see which option is safer for people with atrial fibrillation who are at risk for bleeding.
Hear when a new LVAD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.